Dendi News, Insights and Case Studies

Many labs are blindsided by the limitations of their LIMS for clinical applications. Starting and scaling commercial operations means establishing systems for ordering, billing, data management, and provider connectivity, all while maintaining compliance and service expectations. The key to that transition is shifting from ad-hoc, research-focused LIMS to a clinical-grade Laboratory Information System (LIS).

CliniSys Acquires Orchard Software: What LIS Consolidation Means for Laboratory OwnersOn July 29, 2025 CliniSys announced its acquisition of Orchard Software from private equity firm, Francisco Partne...

The Orchard Software Acquisition: What LIS Consolidation Means for Laboratory OwnersOn July 29, 2025 Clinisys announced its acquisition of Orchard Software from private equity firm, Francisco Partners...

The One Big Beautiful Bill Act has officially passed, and its $880+ billion in Medicaid cuts over five years will fundamentally reshape how diagnostic laboratories operate. While the healthcare industry debates the broader implications, the diagnostic testing market could face an estimated annual reduction of $3.6 billion in Medicaid reimbursement revenue. Independent clinical labs will need to understand the immediate and long-term impacts of these changes and react quickly in order to survive.

ClevelandDx’s Custom IsoPSA Reports Deliver Actionable Prostate Cancer Risk InsightsCleveland Diagnostics, a diagnostic innovator co-founded by the Cleveland Clinic, is advancing precision oncology wi...

Executive War College 2025 Conference Recap (part 3 of 3)Opportunities for Labs in Urgent Care Networks in the Clinical Lab 2.0 EraAt Executive War College 2025, the theme of Clinical Lab 2.0 called f...

Executive War College 2025 Conference Recap (part 2 of 3) How Interoperability and Cloud Platforms Are Powering Clinical Lab 2.0 The clear narrative at EWC this year is that labs that have implemented...

Executive War College 2025 Conference Recap (part 1 of 3)Laying the Foundation for Lab 2.0: the Direct-to-Consumer OpportunityAs labs look to expand in non-traditional diagnostics markets, one growing...

Adela Partners with Dendi to Commercialize Innovative Cancer Detection PlatformDendi’s laboratory information system will support Adela in effectively delivering its MRD clinical diagnostics test to p...

Wren Laboratories Delivers Innovative Cancer Diagnostics with Patient-Centric Lab ReportsWren Laboratories adopted Dendi to preserve their custom reports with minimal transition pain and to enable eff...

Dendi is Exhibiting at ADLM 2024 Clinical Lab ExpoJoin Us in Chicago from July 28 – August 1We’re thrilled to be exhibiting at the ADLM 2024 Clinical Lab Expo! If you’re curious to see what an advance...